Comparison of the Thrombogenicity of Internationally Available Fibrin Sealants in an Established Microsurgical Model
Authors:
- William D. SpotnitzWSWilliam D. Spotnitz
- George T. RodeheaverGRGeorge T. Rodeheaver
- David B. DrakeDDDavid B. Drake
- 1 November 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 108 (6) , 1655-1660
Abstract
Previous studies comparing the thrombotic complications of cryoprecipitated fibrin sealant containing bovine thrombin on microvascular venous anastomoses in a rat epigastric free flap model revealed deleterious outcomes regarding flap survival with higher concentrations of topical bovine thrombin. This study was designed to compare three internationally available fibrin sealants, one experimental fibrin monomer sealant that does not require thrombin, and human thrombin alone as to their effects on the survival of an established rat epigastric free flap model. Ninety Sprague-Dawley rats (400 to 600 g) were prepared for abdominal surgery, and an epigastric-based skin flap was raised. The single vein draining the flap was clamped, divided, and reconnected using standard microvascular suturing techniques. Before release of the clamps, the chosen additive was applied precisely to the anastomosis. Additional material was then added to the raw surface of the flap. The animals were divided into seven treatment groups, each receiving 1 ml of commercial or investigational fibrin sealant or human thrombin alone: one control group receiving no additive treatment, four fibrin sealant groups receiving treatment with commercial or investigational fibrin sealant preparations, and two groups receiving different concentrations (500 IU/ml and 1000 IU/ml) of human thrombin applied to the anastomoses and the surrounding tissue. Flap survival was assessed at 7 days postoperatively. This study supports the contention that microvascular free flap survival based on microvascular venous anastomotic patency was adversely effected by high concentrations of thrombin. Lower concentrations (500 IU/ml and less) of thrombin did not seem to affect flap survival. One test product was composed of a fibrin monomer sealant, which obviates the need for the thrombin additive. This group's survival rate was not statistically different from that of the control group. Thus, for microvascular anastomoses, lower concentrations of thrombin or a sealant devoid of thrombin seem to be best for microvascular anastomotic patency. (Plast. Reconstr. Surg. 108: 1655, 2001.)Keywords
This publication has 18 references indexed in Scilit:
- Acute Thrombogenic Effects of Fibrin Sealant on Microvascular Anastomoses in a Rat ModelAnnals of Plastic Surgery, 1998
- Microvascular anastomosis with minimal suture and fibrin glue: Experimental and clinical studyMicrosurgery, 1998
- THE ROLE OF SUTURES AND FIBRIN SEALANT IN WOUND HEALINGSurgical Clinics of North America, 1997
- The Use of Fibrin Sealant in the Prevention of SeromasPlastic and Reconstructive Surgery, 1997
- Clinical Outcome of Digital Replantation using the Fibrin Glue-Assisted Microvascular Anastomosis TechniqueJournal of Hand Surgery (European Volume), 1996
- Fibrin Glue-assisted End-to-Side Anastomosis of Rat Femoral VesselsAnnals of Plastic Surgery, 1996
- Effect of Fibrinogen and Thrombin Concentrations on Mastectomy Seroma PreventionJournal of Surgical Research, 1996
- Face lifts and sprayed fibrin glue: an outcome analysis of 200 patientsBritish Journal of Plastic Surgery, 1994
- Minimal suture blepharoplasty: Closure of incisions with autologous fibrin glueAesthetic Plastic Surgery, 1992
- A New Method of Skin Graft AdhesionScandinavian Journal of Plastic and Reconstructive Surgery, 1983